Recker Robert R, Deng Hong-Wen
Osteoporis Research Center, Creighton University, Omaha, NE 68131, USA.
Endocrine. 2002 Feb;17(1):55-66. doi: 10.1385/ENDO:17:1:55.
Osteoporosis is a disease characterized by fragile bones and high susceptibility to low-trauma fractures. It is a serious health problem, especially in elderly women. Bone mineral density (BMD) has been employed most commonly as the index for defining and studying osteoporosis. BMD has high genetic determination, with heritability ranging from 50 to 90%. Various gene-mapping approaches have been applied to identify specific genes underlying osteoporosis, largely using BMD as the study phenotype. We review here the genetic determination of osteoporosis as defined by BMD and discuss a fundamental issue we encounter in genetic research in osteoporosis: the choice of phenotype(s) to study. We briefly summarize and discuss advantages and disadvantages of various approaches used in genetic studies of osteoporosis. Finally, we review and discuss the current status for mapping and identification of genes for osteoporosis. We focus on linkage studies in humans and quantitative trait loci mapping in mice to supplement the already extensive reviews of association studies made by many investigators for candidate genes.
骨质疏松症是一种以骨骼脆弱和低创伤性骨折易感性高为特征的疾病。它是一个严重的健康问题,尤其在老年女性中。骨矿物质密度(BMD)最常被用作定义和研究骨质疏松症的指标。BMD具有高度的遗传决定性,遗传度范围为50%至90%。各种基因定位方法已被应用于识别骨质疏松症潜在的特定基因,主要将BMD用作研究表型。我们在此回顾由BMD定义的骨质疏松症的遗传决定性,并讨论我们在骨质疏松症遗传研究中遇到的一个基本问题:研究表型的选择。我们简要总结并讨论骨质疏松症遗传研究中使用的各种方法的优缺点。最后,我们回顾并讨论骨质疏松症基因定位和识别的现状。我们专注于人类的连锁研究和小鼠的数量性状基因座定位,以补充许多研究者对候选基因关联研究已经进行的广泛综述。